Correlation Between RenovoRx and Royalty Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Royalty Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Royalty Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Royalty Pharma Plc, you can compare the effects of market volatilities on RenovoRx and Royalty Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Royalty Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Royalty Pharma.

Diversification Opportunities for RenovoRx and Royalty Pharma

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between RenovoRx and Royalty is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Royalty Pharma Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royalty Pharma Plc and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Royalty Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royalty Pharma Plc has no effect on the direction of RenovoRx i.e., RenovoRx and Royalty Pharma go up and down completely randomly.

Pair Corralation between RenovoRx and Royalty Pharma

Given the investment horizon of 90 days RenovoRx is expected to generate 4.29 times more return on investment than Royalty Pharma. However, RenovoRx is 4.29 times more volatile than Royalty Pharma Plc. It trades about 0.25 of its potential returns per unit of risk. Royalty Pharma Plc is currently generating about -0.05 per unit of risk. If you would invest  100.00  in RenovoRx on August 31, 2024 and sell it today you would earn a total of  26.00  from holding RenovoRx or generate 26.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

RenovoRx  vs.  Royalty Pharma Plc

 Performance 
       Timeline  
RenovoRx 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.
Royalty Pharma Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Royalty Pharma Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

RenovoRx and Royalty Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RenovoRx and Royalty Pharma

The main advantage of trading using opposite RenovoRx and Royalty Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Royalty Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royalty Pharma will offset losses from the drop in Royalty Pharma's long position.
The idea behind RenovoRx and Royalty Pharma Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Directory
Find actively traded commodities issued by global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites